TAKATSU, 1999 - Google Patents
Synthetic Inhibitors of DNA Topoisomerase I and II”TAKATSU, 1999
- Document ID
- 16068391363173505429
- Author
- TAKATSU N
- Publication year
External Links
Snippet
A new type of synthetic inhibitor of DNA topoisomerase I and II was examined and several of these deriva—tives exhibited strong dual activity against these enzymes. This series of compounds showed high cytotoxic activities against cancer cells, but only a limited number …
- 230000002401 inhibitory effect 0 title abstract description 26
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU687350B2 (en) | Indolocarbazole imides and their use | |
| FI86189C (en) | Process for the preparation of therapeutically useful rebeccamycin alloys | |
| US20240400567A1 (en) | Aurora kinase inhibitors for inhibiting mitotic progression | |
| KR100756686B1 (en) | Isomer Conjugation Pyrrolocarbazole and Isoindolelone | |
| JP4555476B2 (en) | Condensed azepinone-type cyclin-dependent kinase inhibitor | |
| IE903801A1 (en) | Camptothecin analogs as potent inhibitors of human¹colorectal cancer | |
| EP1070068B2 (en) | Granulatimide derivatives for use in cancer treatment | |
| CA2155323C (en) | Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof | |
| CH682151A5 (en) | ||
| Bisagni et al. | 1-Amino-substituted 4-methyl-5H-pyrido [4, 3-b] indoles (. gamma.-carbolines) as tricyclic analogs of ellipticines: a new class of antineoplastic agents | |
| Katayama et al. | Synthetic inhibitors of DNA topoisomerase I and II | |
| CA2747359A1 (en) | Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof | |
| CA2245029A1 (en) | Granulatimide compounds as g2 checkpoint inhibitors | |
| HUT59096A (en) | Process for producing indenoindol compounds and pharmaceutical compositions containing them | |
| TAKATSU | Synthetic Inhibitors of DNA Topoisomerase I and II” | |
| KR100588222B1 (en) | Hydroxyalkyl Indolocarbazole Derivatives, Methods of Preparation and Pharmaceutical Compositions Containing Them | |
| CZ280490A3 (en) | Pyridobenzoindole derivatives, process of their preparation and a pharmaceutical containing thereof | |
| AU640831B2 (en) | Process for preparing benzo(c)phenanthridinium derivatives, and novel compounds prepared by said process | |
| AU2002239565B2 (en) | Saframycins, analogues and uses thereof | |
| JP3543196B2 (en) | 6-ethoxy-2- [2 '-(dimethylamino) ethyl] -1,2-dihydro-3H-dibenz (deh) -isoquinoline-1,3-dione | |
| EP1097934B1 (en) | Lk6-a derivatives | |
| CN118125978A (en) | MYC inhibitor and preparation method and application thereof | |
| JPH01221364A (en) | HIV reverse transcriptase inhibitor and antitumor agent | |
| JP2006507269A (en) | Pyrrolo [3,4-c] carbazole and pyrido [2,3-b] pyrrolo [3,4-e] indole derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
| CA2322790C (en) | Granulatimide derivatives for use in cancer treatment |